Mode
Text Size
Log in / Sign up

Lower MAMC and higher MIS associated with cognitive impairment in maintenance hemodialysis patients

Lower MAMC and higher MIS associated with cognitive impairment in maintenance hemodialysis patients
Photo by Marek Pavlík / Unsplash
Key Takeaway
Note that lower MAMC and higher MIS associate with cognitive impairment in hemodialysis patients, but causality is uncertain.

This single-center cross-sectional study evaluated 86 patients undergoing maintenance hemodialysis. The primary exposure was protein-energy wasting, assessed by MAMC and MIS, compared with a non-cognitive impairment group. The primary outcome was cognitive impairment.

Lower MAMC and higher MIS were independently associated with cognitive impairment. For MAMC, the adjusted odds ratio was 0.571 with a 95% CI of 0.400–0.816 and a p-value of 0.002. For MIS, the adjusted odds ratio was 1.249 with a 95% CI of 1.006–1.550 and a p-value of 0.044. In total, 50 patients had cognitive impairment and 36 did not.

The multivariable model demonstrated excellent discriminative ability with an AUC of 0.942 (95% CI 0.898–0.987). Safety data, including adverse events, discontinuations, and tolerability, were not reported. The study had a sample size of 86 patients.

Key limitations include the cross-sectional design, which prevents determination of temporal direction. Causality cannot be established. MAMC and MIS showed stronger and more consistent associations with cognitive impairment than single biochemical markers. Practice relevance is limited by the inability to infer causality.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
ObjectiveThis study aimed to investigate the association between protein-energy wasting (PEW) and cognitive impairment (CI) in patients undergoing maintenance hemodialysis (MHD).MethodsIn this single-center cross-sectional study, 86 patients receiving MHD were enrolled. Nutritional status was assessed using anthropometric measurements, including mid-arm circumference (MAC) and mid-arm muscle circumference (MAMC), as well as the Malnutrition-Inflammation Score (MIS). Cognitive function was evaluated with the Montreal Cognitive Assessment (MoCA), with patients classified into CI (n = 50) and non-CI (n = 36) groups based on education-adjusted scores. Group comparisons, Spearman correlation analysis, multivariable logistic regression, and receiver operating characteristic (ROC) curve analysis were performed.ResultsCognitive impairment was present in 58.1% of the patients. Compared with the non-CI group, patients with CI had a higher Malnutrition–Inflammation Score and lower MAMC. Multivariable logistic regression analysis showed that lower MAMC (adjusted OR 0.571, 95% CI 0.400–0.816, p = 0.002) and higher MIS (adjusted OR 1.249, 95% CI 1.006–1.550, p = 0.044) were independently associated with cognitive impairment. ROC analysis demonstrated that a multivariable model combining age, years of education, dialysis vintage, MAMC, and MIS exhibited excellent discriminative ability (AUC = 0.942, 95% CI 0.898–0.987).ConclusionLower MAMC and higher MIS were independently associated with cognitive impairment in patients undergoing maintenance hemodialysis. These two indicators (MAMC and MIS) showed stronger and more consistent associations with cognitive impairment than single biochemical markers. Given the cross-sectional design of the study, the temporal direction of the association cannot be determined. Prospective studies are warranted to clarify whether muscle loss precedes cognitive decline or occurs as a consequence of it, and to evaluate whether preserving muscle mass can protect cognitive function in this population.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.